Page 3 - Alkermes News Today

The research centre is situated within UL’s Bernal Institute

Alkermes highlighted progress in developing a novel narcolepsy treatment, with a new phase 2 study underway, in its Q1 report.

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) has completed the previously announced sale of its development and manufacturing facility in Athlone, Ireland to...

Alkermes (NASDAQ:ALKS – Get Free Report) posted its earnings results on Wednesday. The company reported $0.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.15), Briefing.com reports. The company had revenue of $350.37 million during the quarter, compared to analyst estimates of $360.26 million. Alkermes had a net margin […]

Alkermes (NASDAQ:ALKS – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.43 EPS for the quarter, missing the consensus estimate of $0.58 by ($0.15), Briefing.com reports. The company had revenue of $350.37 million for the quarter, compared to analyst estimates of $360.26 million. Alkermes had a return on equity of […]

Alkermes (NASDAQ:ALKS – Get Free Report) issued its earnings results on Wednesday. The company reported $0.43 EPS for the quarter, missing the consensus estimate of $0.58 by ($0.15), Briefing.com reports. Alkermes had a return on equity of 16.10% and a net margin of 21.39%. The firm had revenue of $350.37 million during the quarter, compared […]

Throughout the last three months, 7 analysts have evaluated Alkermes (NASDAQ:ALKS), offering a diverse set of opinions from bullish to bearish. Th...

Alkermes (NASDAQ:ALKS – Get Free Report) issued its quarterly earnings results on Wednesday. The company reported $0.43 earnings per share for the quarter, missing the consensus estimate of $0.58 by ($0.15), Briefing.com reports. Alkermes had a return on equity of 16.10% and a net margin of 21.39%. The business had revenue of $350.37 million during […]

InvestorPlace - Stock Market News, Stock Advice & Trading Tips ALKS stock results show that Alkermes missed analyst estimates for earnings per share and…

Alkermes (NASDAQ:ALKS – Get Free Report) is set to post its quarterly earnings results before the market opens on Wednesday, May 1st. Analysts expect Alkermes to post earnings of $0.61 per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link. Alkermes (NASDAQ:ALKS – Get […]